TYK Medicines, Inc. Class H (HK:2410) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TYK Medicines, Inc. has issued a clarification announcement regarding some inadvertent clerical errors in their previous announcement on final offer price and allotment results, with the corrections detailed in an attached blackline document. The company confirmed that other than these clarifications, all other information remains unchanged, including the offer price of HK$12.100, the gross proceeds of HK$579.35 million, and the net proceeds of HK$506.31 million. Investors are cautioned about the high concentration of shareholding, which may lead to substantial price movements with small trades.
For further insights into HK:2410 stock, check out TipRanks’ Stock Analysis page.